Boston Scientific plans US launch of spinal cord stimulator for 2021

Medical device company Boston Scientific is set to launch its WaveWriter Alpha spinal cord stimulator system in the U.S. in the first half of 2021, according to Zacks Equity Research.

Advertisement

Four things to know:

1. WaveWriter has four MRI implantable pulse generators that enable personalized treatment based on the patient’s needs. It offers access to waveforms that cover several areas of chronic pain.

2. The system layers paraesthesia and paraesthesia-free options simultaneously to target nerves along the spinal cord.

3. The global spinal cord stimulation devices market is expected to hit $3.6 billion by 2026, growing at a compound annual growth rate of 8.7 percent, according to Grand View Research.

4. WaveWriter launched in Europe in September. 

More articles on devices:
HCA launches AR spine surgery program at 2nd, 3rd Florida hospitals
2 CEOs on orthopedic consolidation — Don’t grow for the sake of growth alone
175+ spine, orthopedic surgeons on the move in 2020

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.